174 related articles for article (PubMed ID: 38586159)
1. Low Cortisone as a Novel Predictor of the Low-Renin Phenotype.
Tapia-Castillo A; Carvajal CA; Pérez JA; Sandoval A; Allende F; Solari S; Fardella CE
J Endocr Soc; 2024 Apr; 8(6):bvae051. PubMed ID: 38586159
[TBL] [Abstract][Full Text] [Related]
2. Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.
Tapia-Castillo A; Carvajal CA; Pérez JA; Fardella CE
Endocrine; 2022 Aug; 77(2):380-391. PubMed ID: 35676467
[TBL] [Abstract][Full Text] [Related]
3. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
Mosso L; Carvajal C; Campino C; Rojas A; González A; Barraza A; Montero J; Fardella C
Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
[TBL] [Abstract][Full Text] [Related]
4. The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism.
Vecchiola A; Fuentes CA; Barros ER; Martínez-Aguayo A; García H; Allende F; Solari S; Olmos R; Carvajal C; Tapia-Castillo A; Campino C; Kalergis AM; Baudrand R; Fardella CE
Am J Hypertens; 2019 Apr; 32(5):468-475. PubMed ID: 30753255
[TBL] [Abstract][Full Text] [Related]
5. Urinary free cortisol is not a biochemical marker of hypertension.
Krall P; Carvajal C; Ortiz E; Muñoz C; Garrido JL; Mosso L; Fardella C
Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
[TBL] [Abstract][Full Text] [Related]
6. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
7. Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome.
Carvajal CA; Tapia-Castillo A; Vecchiola A; Baudrand R; Fardella CE
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31909799
[TBL] [Abstract][Full Text] [Related]
8. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
Ferrari P; Lovati E; Frey FJ
J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
[TBL] [Abstract][Full Text] [Related]
10. Continuum of Renin-Independent Aldosteronism in Normotension.
Baudrand R; Guarda FJ; Fardella C; Hundemer G; Brown J; Williams G; Vaidya A
Hypertension; 2017 May; 69(5):950-956. PubMed ID: 28289182
[TBL] [Abstract][Full Text] [Related]
11. Cortisol/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension.
Martinez-Aguayo A; Campino C; Baudrand R; Carvajal CA; García H; Aglony M; Bancalari R; García L; Loureiro C; Vecchiola A; Tapia-Castillo A; Valdivia C; Sanhueza S; Fuentes CA; Lagos CF; Solari S; Allende F; Kalergis AM; Fardella CE
J Hypertens; 2016 Sep; 34(9):1808-14. PubMed ID: 27488551
[TBL] [Abstract][Full Text] [Related]
12. Serum Cortisol and Cortisone as Potential Biomarkers of Partial 11β-Hydroxysteroid Dehydrogenase Type 2 Deficiency.
Carvajal CA; Tapia-Castillo A; Valdivia CP; Allende F; Solari S; Lagos CF; Campino C; Martínez-Aguayo A; Vecchiola A; Pinochet C; Godoy C; Iturrieta V; Baudrand R; Fardella CE
Am J Hypertens; 2018 Jul; 31(8):910-918. PubMed ID: 29617893
[TBL] [Abstract][Full Text] [Related]
13. Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.
Hundemer GL; Baudrand R; Brown JM; Curhan G; Williams GH; Vaidya A
J Clin Endocrinol Metab; 2017 Jun; 102(6):1835-1843. PubMed ID: 28323995
[TBL] [Abstract][Full Text] [Related]
14. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
[TBL] [Abstract][Full Text] [Related]
15. Clinical, Biochemical, and Genetic Characteristics of "Nonclassic" Apparent Mineralocorticoid Excess Syndrome.
Tapia-Castillo A; Baudrand R; Vaidya A; Campino C; Allende F; Valdivia C; Vecchiola A; Lagos CF; Fuentes CA; Solari S; Martínez-Aguayo A; García H; Carvajal CA; Fardella CE
J Clin Endocrinol Metab; 2019 Feb; 104(2):595-603. PubMed ID: 30239803
[TBL] [Abstract][Full Text] [Related]
16. [Free urinary cortisol is elevated in patients with low-renin essential hypertension].
Krall P; Mosso L; Carvajal C; Rojas A; Fardella C
Rev Med Chil; 2004 Sep; 132(9):1053-9. PubMed ID: 15543761
[TBL] [Abstract][Full Text] [Related]
17. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.
Walker BR; Stewart PM; Shackleton CH; Padfield PL; Edwards CR
Clin Endocrinol (Oxf); 1993 Aug; 39(2):221-7. PubMed ID: 8370136
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives.
Carvajal CA; Romero DG; Mosso LM; González AA; Campino C; Montero J; Fardella CE
J Hypertens; 2005 Jan; 23(1):71-7. PubMed ID: 15643127
[TBL] [Abstract][Full Text] [Related]
19. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
20. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]